Genotyping Assay Market worth $44.60 billion by 2031
The report "Genotyping Assay Market by Product (Reagents & Kits, Instruments, Bioinformatics), Technology (PCR, NGS, Capillary Electrophoresis, Microarray), Application (Diagnostics, Agricultural Biotechnology), Competition, End User, Region – Global Forecast to 2031", The global genotyping assays market is projected to reach USD 44.60 billion by 2031, up from USD 24.29 billion in 2026, at a CAGR of 12.9% during the forecast period. The global genotyping assays market is experiencing significant growth, driven by technological advances in DNA sequencing and PCR-based technologies, the rising prevalence of genetic disorders, and the growing adoption of personalized medicine and pharmacogenomics. Expanding applications of genotyping in drug discovery and development, expanding genomic research, and increasing demand for accurate genetic variant identification are further supporting market expansion.
Browse 444 market data Tables and 56 Figures spread through 370 Pages and in-depth TOC on "Genotyping Assay Market by Product (Reagents & Kits, Instruments, Bioinformatics), Technology (PCR, NGS, Capillary Electrophoresis, Microarray), Application (Diagnostics, Agricultural Biotechnology), Competition, End User, Region – Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html
The reagents & kits segment accounted for the largest share of the global genotyping assay market, by product, in 2025.
By product, the genotyping assays market is segmented into reagents & kits, genotyping services, instruments, and bioinformatics. The reagents & kits segment accounted for the largest share of the market in 2025, driven by recurring demand for PCR reagents, sequencing kits, genotyping arrays, and other consumables required for genetic analysis. Increasing adoption of pharmacogenomics, personalized medicine, and genomic research, along with the growing need for reliable, high-throughput genetic testing, supports the segment's leading position.
The sequencing segment is projected to be the fastest-growing technology segment in the genotyping assays market.
The global genotyping assays market is segmented by technology into PCR, sequencing, microarrays, and other technologies. During the forecast period, the sequencing segment is expected to grow strongly, driven by advances in next-generation sequencing (NGS), falling sequencing costs, and rising demand for comprehensive genetic variant detection. Expanding applications in rare disease research, oncology, pharmacogenomics, and precision medicine are further supporting adoption. Improvements in sequencing throughput, accuracy, and data analysis capabilities are expected to accelerate the adoption of sequencing-based genotyping solutions across research and clinical applications.
North America accounted for the largest regional share of the global genotyping assays market in 2025.
The genotyping assays market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, North America accounted for the largest share of the global market, driven by a strong presence of pharmaceutical and biotechnology companies, advanced research infrastructure, and the widespread adoption of genomic technologies. The region benefits from substantial investments in genomics research, precision medicine, and drug discovery, as well as the presence of leading genotyping assay manufacturers and technology developers. The growing applications of genetic testing in disease diagnosis, pharmacogenomics, and personalized medicine, supported by collaborations among research institutions, healthcare organizations, and biotechnology companies, further strengthen the region's market position.
Key players in the genotyping assays market include Thermo Fisher Scientific (US), Illumina, Inc. (US), QIAGEN N.V. (Germany), Roche Diagnostics (Switzerland), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Standard BioTools Inc. (US), Pacific Biosciences of California, Inc. (US), Oxford Nanopore Technologies plc (UK), Revvity, Inc. (US), Eurofins Scientific SE (Luxembourg), and Takara Bio Inc. (Japan).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Genotyping Assay Market
- What will your New Revenue Sources be
- Who will be your Top Customer; what will make them switch
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
